Jurgis Alvikas

University of Pittsburgh Medical Center

Papers

1

Total Citations

13

H-Index

1

About

Jurgis Alvikas is a surgeon-scientist whose research centers on optimizing surgical outcomes for patients with primary and secondary liver malignancies, particularly hepatocellular carcinoma (HCC) and colorectal cancer liver metastasis (CRLM). His most cited work, a 2023 study on patient selection for laparoscopic versus open liver resection, addresses a critical clinical challenge: balancing the benefits of minimally invasive surgery with the need for complete oncologic resection. By analyzing outcomes in these two most common tumor types requiring liver resection, Alvikas provides evidence-based guidance for surgical decision-making, especially in settings where liver transplantation—the gold standard for HCC—is limited by organ shortages and high costs. His work has already garnered 13 citations, reflecting its immediate relevance to practicing hepatobiliary surgeons. Alvikas’s contributions are particularly valuable for clinicians navigating the complex trade-offs between surgical approach and patient prognosis. His research underscores a commitment to refining surgical techniques and patient selection criteria to improve survival and quality of life for those facing limited treatment options.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes and Patient Selection in Laparoscopic vs. Open Liver Resection for HCC and Colorectal Cancer Liver Metastasis
13 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: University of Pittsburgh Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago